SOPHiA GENETICS (SOPH) Scheduled to Post Quarterly Earnings on Tuesday

SOPHiA GENETICS (NASDAQ:SOPH - Get Free Report) will announce its earnings results before the market opens on Tuesday, May 7th. Analysts expect the company to announce earnings of ($0.28) per share for the quarter. Investors interested in participating in the company's conference call can do so using this link.

SOPHiA GENETICS (NASDAQ:SOPH - Get Free Report) last released its quarterly earnings data on Tuesday, March 5th. The company reported ($0.37) earnings per share for the quarter, missing the consensus estimate of ($0.25) by ($0.12). SOPHiA GENETICS had a negative net margin of 126.63% and a negative return on equity of 47.40%. The company had revenue of $17.05 million during the quarter, compared to the consensus estimate of $16.78 million. During the same quarter in the prior year, the company posted ($0.22) earnings per share. On average, analysts expect SOPHiA GENETICS to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

SOPHiA GENETICS Price Performance

Shares of SOPHiA GENETICS stock traded up $0.04 during midday trading on Tuesday, hitting $5.10. 43,117 shares of the company were exchanged, compared to its average volume of 58,917. The firm has a 50 day simple moving average of $4.91 and a 200-day simple moving average of $4.51. The firm has a market cap of $332.67 million, a P/E ratio of -4.18 and a beta of 1.17. SOPHiA GENETICS has a 52 week low of $2.13 and a 52 week high of $7.37.

Wall Street Analyst Weigh In

SOPH has been the topic of several recent analyst reports. BTIG Research boosted their target price on shares of SOPHiA GENETICS from $7.00 to $8.00 and gave the company a "buy" rating in a research note on Wednesday, March 6th. Royal Bank of Canada restated an "outperform" rating and issued a $8.00 price target on shares of SOPHiA GENETICS in a research report on Wednesday, March 6th.

About SOPHiA GENETICS

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific.